A Cross-sectional Study in Type 2 Diabetes Patients Reveals That Elevated Pulse Wave Velocity Predicts Asymptomatic Peripheral Arterial Disease Associated with Age and Diabetes Duration

Overview

Journal Int J Cardiol Heart Vasc

Date 2024 Jan 4

PMID 38173786

Authors

Dora Gasparini

Anamaria Zuljani

Felix M Wensveen

Tamara Turk Wensveen

Affiliations

Soon will be listed here.

Abstract

Background: Peripheral arterial disease (PAD) reduces functional capacity and raises cardiovascular risks, but underdiagnosis is common, resulting in less comprehensive care than other cardiovascular conditions. While diabetes has long been viewed as a key risk factor for PAD, recent studies indicate that its impact is influenced by the presence of concurrent cardiovascular risk factors. The aim of this study is to elucidate the intricate relationship between the prevalence of PAD, diabetic complications, and cardiovascular risk factors among asymptomatic patients with type 2 diabetes mellitus (T2DM).

Methods: Ninety-one patients with T2DM and no symptoms or previous diagnosis of PAD were recruited from the outpatient diabetic clinic. Clinical data were extracted from electronic medical records, and the screening for PAD was conducted using MESI mTABLET.

Results: Screening for PAD among asymptomatic individuals with T2DM revealed that 5.49 % of patients exhibit a low ankle-brachial index (ABI). Patients who had previously experienced major adverse cardiovascular events or exhibited albuminuria displayed lower ABI values. Furthermore, a striking 45.05 % of the participants displayed an abnormally high carotid-femoral pulse wave velocity (cfPWV) value, with elevated PWV values correlating with advanced age and longer diabetes duration.

Conclusions: The prevalence of elevated cfPWV is more pronounced than that of decreased ABI in T2DM patients with asymptomatic PAD and is associated with older age and longer diabetes duration, therefore measurement of both ABI and PWV is crucial for the cardiovascular risk assessment protocol for patients with T2DM and timely PAD diagnosis.

References

Liu H, Xie W, Liu J, Zhao H, Wu Y, Wang H . Comparison of vascular-related diseases in their associations with carotid femoral pulse wave velocity: From the Beijing Vascular Disease Patients Evaluation Study (BEST Study). Int J Clin Pract. 2019; 73(11):e13400. DOI: 10.1111/ijcp.13400. View

Paul S, Bhatt D, Montvida O . The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study. Eur Heart J. 2020; 42(18):1728-1738. DOI: 10.1093/eurheartj/ehaa956. View

Busch L, Heinen Y, Stern M, Wolff G, Ozaslan G, Tzetou K . Angioplasty of Flow-Limiting Stenosis Reduces Aortic and Brachial Blood Pressure in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2021; 10(14):e019724. PMC: 8483469. DOI: 10.1161/JAHA.120.019724. View

Mattace-Raso F, van der Cammen T, Hofman A, van Popele N, Bos M, Schalekamp M . Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006; 113(5):657-63. DOI: 10.1161/CIRCULATIONAHA.105.555235. View

Nakano H, Okazaki K, Ajiro Y, Suzuki T, Oba K . Clinical usefulness of measuring pulse wave velocity in predicting cerebrovascular disease: evaluation from a cross-Sectional and longitudinal follow-up study. J Nippon Med Sch. 2001; 68(6):490-7. DOI: 10.1272/jnms.68.490. View

Xu Y, Wu Y, Li J, Ma W, Guo X, Luo Y . The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients. Hypertens Res. 2008; 31(6):1079-85. DOI: 10.1291/hypres.31.1079. View

Catalano M, Scandale G, Carzaniga G, Cinquini M, Minola M, Antoniazzi V . Aortic augmentation index in patients with peripheral arterial disease. J Clin Hypertens (Greenwich). 2014; 16(11):782-7. PMC: 8031844. DOI: 10.1111/jch.12406. View

Piko N, Bevc S, Hojs R, Naji F, Ekart R . The association between pulse wave analysis, carotid-femoral pulse wave velocity and peripheral arterial disease in patients with ischemic heart disease. BMC Cardiovasc Disord. 2021; 21(1):33. PMC: 7807526. DOI: 10.1186/s12872-021-01859-0. View

Wannamethee S, Shaper A, Whincup P, Lennon L, Sattar N . Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011; 171(5):404-10. DOI: 10.1001/archinternmed.2011.2. View

10.

Laurent S, Katsahian S, Fassot C, Tropeano A, Gautier I, Laloux B . Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34(5):1203-6. DOI: 10.1161/01.STR.0000065428.03209.64. View

11.

Song P, Rudan D, Zhu Y, Fowkes F, Rahimi K, Fowkes F . Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019; 7(8):e1020-e1030. DOI: 10.1016/S2214-109X(19)30255-4. View

12.

Wohlfahrt P, Palous D, Ingrischova M, Krajcoviechova A, Seidlerova J, Galovcova M . A high ankle-brachial index is associated with increased aortic pulse wave velocity: the Czech post-MONICA study. Eur J Cardiovasc Prev Rehabil. 2011; 18(6):790-6. DOI: 10.1177/1741826711398840. View

13.

Laugesen E, Hoyem P, Fleischer J, Kumarathas I, Knudsen S, Hansen K . Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes. Am J Hypertens. 2016; 29(10):1165-72. DOI: 10.1093/ajh/hpw066. View

14.

Ishida A, Miyagi M, Kinjo K, Ohya Y . Age- and sex-related effects on ankle-brachial index in a screened cohort of Japanese: the Okinawa Peripheral Arterial Disease Study (OPADS). Eur J Prev Cardiol. 2012; 21(6):712-8. DOI: 10.1177/2047487312462822. View

15.

Coutinho T, Turner S, Kullo I . Aortic pulse wave velocity is associated with measures of subclinical target organ damage. JACC Cardiovasc Imaging. 2011; 4(7):754-61. PMC: 3862768. DOI: 10.1016/j.jcmg.2011.04.011. View

16.

Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016; 135(12):e686-e725. PMC: 5479414. DOI: 10.1161/CIR.0000000000000470. View

17.

Olin J, White C, Armstrong E, Kadian-Dodov D, Hiatt W . Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options. J Am Coll Cardiol. 2016; 67(11):1338-57. DOI: 10.1016/j.jacc.2015.12.049. View

18.

YaQoub L, Peri-Okonny P, Wang J, Patel K, Stone N, Smolderen K . Blood pressure management in patients with symptomatic peripheral artery disease: insights from the PORTRAIT registry. Eur Heart J Qual Care Clin Outcomes. 2018; 5(1):79-81. PMC: 6307328. DOI: 10.1093/ehjqcco/qcy035. View

19.

. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S17-S38. DOI: 10.2337/dc22-S002. View

20.

Mosimann K, Jacomella V, Thalhammer C, Meier T, Kohler M, Amann-Vesti B . Severity of peripheral arterial disease is associated with aortic pressure augmentation and subendocardial viability ratio. J Clin Hypertens (Greenwich). 2012; 14(12):855-60. PMC: 8108840. DOI: 10.1111/j.1751-7176.2012.00702.x. View